NCT02852902View on ClinicalTrials.gov

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.

CompletedOBSERVATIONAL

Enrollment

820

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

January 1, 2018

Conditions

Clinically Significant BacteremiaOrgan TransplantationInfectionBacteremiaBacterial InfectionsSepsisSystemic Inflammatory Response SyndromePathologic ProcessesInflammation

Trial Locations (3)

14004

Hospital Universitario Reina Sofía/IMIBIC/Universidad de Córdoba, Córdoba

28041

12 de Octubre University Hospital, Madrid

41009

Virgen Macarena University Hospital, Seville

All Listed Sponsors

collaborator

European Society of Clinical Microbiology and Infectious Diseases

OTHER

lead

Spanish Network for Research in Infectious Diseases

OTHER

NCT02852902 - Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study. | Biotech Hunter | Biotech Hunter